Data / Form D filings / BioExx Specialty Proteins Ltd.
BioExx Specialty Proteins Ltd.: Form D filings
BioExx Specialty Proteins Ltd., a biotechnology company in Toronto, Ontario, Canada, filed 5 Form D notices with the SEC between 2009 and 2011. The latest, on July 15, 2011, reports $2.3 million sold of a $2.3 million offering to 4 investors.
Find out what BioExx Specialty Proteins Ltd. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 219 DUFFERIN STREET, SUITE 100B, Toronto, Ontario, Canada, M6K 3
- Phone
- (416) 588-4442
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Ontario, Canada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1465222
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 15, 2011 | New notice | $2,284,354 | $2,284,354 | $0 | 4 | Jun 30, 2011 | sec.gov |
| Sep 8, 2010 | New notice | $1,524,806 | $1,524,806 | $0 | 7 | Aug 24, 2010 | sec.gov |
| Apr 16, 2010 | New notice | $1,313,218 | $1,313,218 | $0 | 3 | Mar 30, 2010 | sec.gov |
| Nov 9, 2009 | New notice | $3,771,308 | $3,771,308 | $0 | 21 | Oct 15, 2009 | sec.gov |
| Jun 10, 2009 | New notice | $827,608 | $827,608 | $0 | 4 | May 14, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Will D. Ollerhead | Director | |
| Samah D. Garringer | Executive Officer | |
| John D. MacDonald | Director | |
| Christopher D. Carl | Executive Officer, Director | |
| Henry D. Linsert | Director | |
| Peter D. Lacey | Director | |
| Chris D. Schnarr | Executive Officer, Director | |
| Clinton D. Smith | Executive Officer |
Every Form D from the week of Jul 11, 2011 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what BioExx Specialty Proteins Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.